---
title: "EP Biocomposites Ltd (543595) — Share Price, Financials & Analysis"
symbol: "543595"
company: "EP Biocomposites Ltd"
canonical: "https://tapetide.com/stocks/543595"
isin: "INE0D2I01014"
nse_symbol: "EPBIOCOMPOSITESLTD"
bse_code: "543595"
sector: "Utilities"
industry: "Waste Management"
market_cap_cr: 17.8
generated_at: "2026-09-13T20:15:47.564Z"
---

# EP Biocomposites Ltd (543595)

Canonical page: https://tapetide.com/stocks/543595

## Company

- **NSE Symbol:** EPBIOCOMPOSITESLTD
- **BSE Code:** 543595
- **ISIN:** INE0D2I01014
- **Sector:** Utilities
- **Industry:** Waste Management
- **Macro Sector:** Utilities
- **Stock Type:** EQUITY
- **Listed Since:** 2022-09-13
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** epbiocomposites.com

## About

Incorporated in 2020, EP Biocomposites Ltd manufactures fibre reinforced polymer products and provides bio toilet solutions[1]

## Latest Price

## Key Fundamentals

Observed at 2026-09-11T04:36:30.483654Z.

- **Market Cap:** ₹17.8 Cr
- **Classification:** SME
- **P/E (reported):** 12.2
- **EPS (reported):** ₹6.84
- **Book Value:** ₹71.67
- **Price to Book:** 1.48
- **Dividend Yield:** 0%
- **ROE:** 9.73%
- **ROCE:** 13.57%
- **Debt to Equity:** 0.2
- **Revenue (yearly):** ₹12.1 Cr
- **Net Income:** ₹1 Cr
- **EBITDA:** ₹1.9 Cr
- **52-Week High:** ₹149.9
- **52-Week Low:** ₹75.5
- **RSI (14):** 55.62

## Key Insights

### Weaknesses

- Though the company is reporting repeated profits, it is not paying out dividend
- Company has a low return on equity of 12.0% over last 3 years.
- Company has high debtors of 317 days.

## Growth Rates

| Metric | 1Y | 3Y | 5Y |
| --- | --- | --- | --- |
| cash flow growth | 60.48% | 37.97% | — |
| ebitda margin growth | 7.02% | 1.63% | -1.14% |
| net income growth | -9.09% | 36% | 32% |
| revenue growth | 3.42% | 24% | 36% |
| roce | -9.83% | 28.63% | 37.98% |
| roe | -19.05% | 9.53% | -89.5% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2021 | Mar 2022 | Sep 2022 | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 2.76 | 5.3 | 3.45 | 3.68 | 4.4 | 7.04 | 4.4 | 7.6 | 4.07 | 9.57 |
| Expenses | 2.42 | 4.27 | 2.92 | 3.26 | 4.14 | 5.9 | 3.91 | 6.31 | 3.82 | 7.58 |
| Operating Profit | 0.34 | 1.03 | 0.53 | 0.42 | 0.26 | 1.14 | 0.49 | 1.29 | 0.25 | 1.99 |
| OPM % | 12.32 | 19.43 | 15.36 | 11.41 | 5.91 | 16.19 | 11.14 | 16.97 | 6.14 | 20.79 |
| Other Income | 0 | 0.01 | 0.03 | 0.13 | 0.09 | 0.21 | 0.05 | 0.06 | 0.07 | 0.07 |
| Interest | 0.02 | 0.13 | 0.15 | 0.05 | 0.01 | 0.02 | 0.17 | 0.19 | 0.15 | 0.19 |
| Depreciation | 0.01 | 0.06 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.06 | 0.05 | 0.05 |
| Profit before tax | 0.31 | 0.85 | 0.36 | 0.45 | 0.29 | 1.28 | 0.32 | 1.1 | 0.12 | 1.82 |
| Tax % | 25.81 | 32.94 | 25 | 33.33 | 27.59 | 27.34 | 34.38 | 25.45 | 33.33 | 24.73 |
| Net Profit | 0.24 | 0.57 | 0.27 | 0.3 | 0.22 | 0.93 | 0.21 | 0.83 | 0.09 | 1.37 |
| EPS in Rs | 2.04 | 4.84 | 1.61 | 1.78 | 1.31 | 5.53 | 1.25 | 4.94 | 0.54 | 8.15 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2020 3m | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 0.57 | 2.95 | 8.06 | 7.12 | 11.43 | 12.01 | 13.64 |
| Expenses | 0.53 | 2.49 | 6.66 | 6.15 | 10.02 | 10.23 | 11.4 |
| Operating Profit | 0.04 | 0.46 | 1.4 | 0.97 | 1.41 | 1.78 | 2.24 |
| OPM % | 7.02 | 15.59 | 17.37 | 13.62 | 12.34 | 14.82 | 16.42 |
| Other Income | 0 | 0 | 0.02 | 0.17 | 0.3 | 0.11 | 0.14 |
| Interest | 0 | 0 | 0.19 | 0.23 | 0.04 | 0.36 | 0.34 |
| Depreciation | 0 | 0 | 0.07 | 0.1 | 0.1 | 0.11 | 0.1 |
| Profit before tax | 0.04 | 0.46 | 1.16 | 0.81 | 1.57 | 1.42 | 1.94 |
| Tax % | 25 | 23.91 | 31.03 | 28.4 | 26.75 | 27.46 | 24.74 |
| Net Profit | 0.03 | 0.36 | 0.81 | 0.58 | 1.15 | 1.03 | 1.46 |
| EPS in Rs | 6 | 72 | 6.88 | 3.45 | 6.84 | 6.13 | 8.68 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 | 0 | 0 |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 0.05 | 0.05 | 1.18 | 1.68 | 1.68 | 1.68 | 1.68 |
| Reserves | -0.02 | 0.34 | 0.82 | 6.73 | 7.88 | 8.91 | 10.37 |
| Borrowings | 0 | 0 | 4.11 | 1.28 | 1.8 | 2.98 | 2.4 |
| Other Liabilities | 0.52 | 0.94 | 3.16 | 2.03 | 3.72 | 3.06 | 4.28 |
| Total Liabilities | 0.55 | 1.33 | 9.27 | 11.72 | 15.08 | 16.63 | 18.73 |
| Fixed Assets | 0 | 0 | 0.41 | 0.33 | 0.33 | 0.23 | 0.23 |
| CWIP | 0 | 0 | 0 | 0 | 0.14 | 0.14 | 0.62 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 0.55 | 1.33 | 8.86 | 11.39 | 14.61 | 16.26 | 17.88 |
| Total Assets | 0.55 | 1.33 | 9.27 | 11.72 | 15.08 | 16.63 | 18.73 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 0.12 | 0.03 | -4.28 | -0.79 | -1.24 | -0.49 | 1.99 |
| Cash from Investing Activity | 0 | 0 | -0.47 | 0.02 | -0.16 | 0.02 | -0.53 |
| Cash from Financing Activity | 0 | 0 | 4.76 | 2.81 | 0.49 | 0.82 | -0.92 |
| Net Cash Flow | 0.12 | 0.03 | 0.01 | 2.04 | -0.92 | 0.35 | 0.54 |
| Free Cash Flow | 0.12 | 0.03 | -4.75 | -0.81 | -1.48 | -0.5 | 1.41 |
| CFO/OP | 300 | 9 | -294 | -44 | -59 | -1 | 105 |

### Ratios

| Item | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 192.11 | 80.42 | 321.53 | 300.41 | 287.4 | 330.05 | 316.83 |
| Inventory Days | 83.65 | 90.25 | 86.83 | 90.58 | 50.13 | 66.66 | 56.54 |
| Days Payable | 349.79 | 128.35 | 161.9 | 104.79 | 143.08 | 97.87 | 113.51 |
| Cash Conversion Cycle | -74.04 | 42.32 | 246.47 | 286.2 | 194.45 | 298.85 | 259.87 |
| Working Capital Days | -57.63 | 25.98 | 156.69 | 255.81 | 217.47 | 270.79 | 237.62 |
| ROCE % | — | 219.05 | 41.54 | 13.16 | 15.3 | 14.28 | 16.27 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 70.08% | 70.08% | 70.08% | 70.08% | 70.08% | 70.08% | 70.08% | 70.08% | 70.05% | 70.08% | 70.08% | 70.08% |
| FIIs | 2.2% | 2.2% | 2.2% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| DIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 22.69% | 23.97% | 23.47% | 24.69% | 24.69% | 25.67% | 26.41% | 26.05% | 26.35% | 26.5% | 26.83% | 26.62% |
| Others | 5.03% | 3.75% | 4.25% | 5.23% | 5.23% | 4.25% | 3.51% | 3.87% | 3.6% | 3.42% | 3.09% | 3.3% |
| No. of Shareholders | 315 | 329 | 339 | 374 | 365 | 365 | 382 | 374 | 361 | 356 | 353 | 337 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Buy
- **Buy / Neutral / Sell:** 10 / 5 / 4

### Moving Averages — summary: **Strong Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 95.39 | Buy |
| EMA (10) | 97.47 | Buy |
| SMA (20) | 98.1 | Buy |
| EMA (20) | 97.53 | Buy |
| SMA (50) | 98.09 | Buy |
| EMA (50) | 98.42 | Buy |
| SMA (100) | 98.28 | Buy |
| EMA (100) | 102.15 | Buy |
| SMA (200) | 109.77 | Sell |
| EMA (200) | 112.93 | Sell |

### Oscillators — summary: **Neutral**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 55.62 | Neutral |
| MACD (12,26,9) | -0.33 | Buy |
| Stochastic (14,3,3) | 62.72 | Neutral |
| ADX (14) | 12.73 | Neutral |
| Williams %R (14) | -7.14 | Sell |
| ATR (14) | 8.22 | High Volatility |
| ROC (12) | 10.2 | Buy |
| Stoch RSI (14) | 100 | Sell |
| UO (7,14,28) | 65.2 | Neutral |

## Filings & Documents

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-09-04 | [Intimation Of The Seventh Annual General Meeting To Be Held On September 28 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=adb1d4c6-1230-4ace-876c-2e0a70b16d7f.pdf) |
| 2026-09-04 | [Reg. 34 (1) Annual Report.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bfb53cef-e3cb-4917-9bbd-d605beb36346.pdf) |
| 2026-05-29 | [Press Release On The Financial Results For The Half Year And Year Ended March 31 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=581774ba-28f1-409c-af41-ebe91743b7b8.pdf) |
| 2026-05-26 | [Board Meeting Outcome for Outcome Of The Board Meeting Along With The Financial Results For The Year Ended March 31 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b1ffe333-a773-423a-8a3a-ddced4f94058.pdf) |
| 2026-05-20 | [Board Meeting Intimation for Board Meeting Scheduled To Approve The Financial Results For The Year Ended March 31 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7993e073-fd8d-4f39-93fd-3afb144c94e7.pdf) |
| 2026-03-31 | [Closure of Trading Window](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8416d6f4-6e7b-4a1b-9a3a-33473840d2e8.pdf) |
| 2026-02-18 | [Intimation Of Press Release - EP Biocomposites Strengthens Technology Capabilities Through Strategic Collaboration With Iisc Bengaluru](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=65874a28-bd01-4103-bc45-e8152a69046b.pdf) |
| 2026-02-17 | [Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ce16f57c-a116-4285-b46d-fa1c097e5d1a.pdf) |
| 2026-01-22 | [Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e30788c8-d2d6-4e3c-a2f5-9d5ba2a0d0c5.pdf) |
| 2025-11-03 | [Board Meeting Outcome for Outcome Of The Board Meeting- Financial Results For The Half Year Ended September 30 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5c06a28e-a90a-4030-bf4b-f99a53a17eeb.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-05-26 | [Financial Results For The Year Ended March 31 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=251150e8-ed79-4857-94d8-771dafdf4f9f.pdf) |
| 2025-11-03 | [Financial Results For The Half Year Ended September 30 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2f2aa925-5bc0-467d-9f0e-68c4124e5a27.pdf) |
| 2024-11-13 | [Results- Financial Results For The Half-Year Ended September 30, 2024 Along With Limited Review Report](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=42b50971-8856-4cff-b2d8-d41198bbfc16.pdf) |
| 2024-05-24 | [Financial Results For The Year Ended 31 March 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6ab8df6a-2b05-41f7-a0cf-0d3d00d8f219.pdf) |
| 2023-11-14 | [Unaudited Financial Results For The Half Year Ended September 30, 2023 With Statement Of Assets And Liabilities](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7343cdce-3fd7-44c0-aef7-5485f9334f0b.pdf) |
| 2023-05-29 | [Board Meeting Outcome for Outcome Of Board Meeting & Submission Of Audited Financial Statements For Year Ended March 31, 2023<BR>](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fbc65c1c-4e95-49fb-80ee-006cdd20b7b0.pdf) |
| 2022-11-12 | [Outcome Of Board Meeting Dated, 12.11.2022 For Adoption Of Unaudited Financial Results For Half Year Ended September 30, 2022](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6ae17821-2168-4383-8e40-096c0c848622.pdf) |

### Other Documents

| Date | Document |
| --- | --- |
| 3 Nov 2025 - Unaudited H1 FY2025 results: Revenue Rs.407.48L, PAT Rs.9.04L, EPS 0.54; approved Nov 3, 2025. | [Board Meeting Outcome for Outcome Of The Board Meeting- Financial Results For The Half Year Ended September 30, 2025 3 Nov 2025 - Unaudited H1 FY2025 results: Revenue Rs.407.48L, PAT Rs.9.04L, EPS 0.54; approved Nov 3, 2025.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/5c06a28e-a90a-4030-bf4b-f99a53a17eeb.pdf) |
| 3 Nov 2025 - Board approved unaudited H1 results to Sept 30, 2025: revenue Rs407.48L, PAT Rs9.04L, EPS Rs0.54. | [Financial Results For The Half Year Ended September 30, 2025 3 Nov 2025 - Board approved unaudited H1 results to Sept 30, 2025: revenue Rs407.48L, PAT Rs9.04L, EPS Rs0.54.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/2f2aa925-5bc0-467d-9f0e-68c4124e5a27.pdf) |
| 24 Feb - Transcript of the earnings conference call is available in the investor information section of the website of the Company at the web-link https://ranegroup.com/investors/rane-holdings-limited/. | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript 24 Feb - Transcript of the earnings conference call is available in the investor information section of the website of the Company at the web-link https://ranegroup.com/investors/rane-holdings-limited/.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/1e6cb6b6-ddac-47f6-960b-65f1114bca3d.pdf) |
| 24 Feb - Copy of the adverisements published on February 24, 2026 in Newspapers - Business Standard (English) and Hindu Tamizh Thisai (Tamil) in connection with the Postal … | [Announcement under Regulation 30 (LODR)-Newspaper Publication 24 Feb - Copy of the adverisements published on February 24, 2026 in Newspapers - Business Standard (English) and Hindu Tamizh Thisai (Tamil) in connection with the Postal …](https://www.bseindia.com/xml-data/corpfiling/AttachHis/fafd91f9-ce3c-4b0f-b6f2-867997a5a3d4.pdf) |
| 22 Jan - Received INR 2.15 crore order for 1,000 Model IV benches, supply/install by 31-03-2027. | [Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order 22 Jan - Received INR 2.15 crore order for 1,000 Model IV benches, supply/install by 31-03-2027.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/e30788c8-d2d6-4e3c-a2f5-9d5ba2a0d0c5.pdf) |
| 18 Feb - EP Biocomposites partners with IISc Bengaluru on non-biological wastewater treatment R&D, announced 18 Feb 2026. | [Intimation Of Press Release - EP Biocomposites Strengthens Technology Capabilities Through Strategic Collaboration With Iisc Bengaluru 18 Feb - EP Biocomposites partners with IISc Bengaluru on non-biological wastewater treatment R&D, announced 18 Feb 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/65874a28-bd01-4103-bc45-e8152a69046b.pdf) |
| 17 Feb - Audio/video recording of Feb 17, 2026 earnings conference call posted on company's investor website. | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome 17 Feb - Audio/video recording of Feb 17, 2026 earnings conference call posted on company's investor website.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/d8506939-2004-4566-97e6-e344f162a975.pdf) |
| 17 Feb - 17 Feb 2026: Agreement with IISc Bengaluru for technical consultancy on non-biological wastewater recycling. | [Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements 17 Feb - 17 Feb 2026: Agreement with IISc Bengaluru for technical consultancy on non-biological wastewater recycling.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/ce16f57c-a116-4285-b46d-fa1c097e5d1a.pdf) |
| 16 Feb - Copy of the earnings presentation. This is also being made available on the investor section of the website of the Company at the weblink https://ranegroup.com/investors/rane-holdings-limited/. | [Announcement under Regulation 30 (LODR)-Investor Presentation 16 Feb - Copy of the earnings presentation. This is also being made available on the investor section of the website of the Company at the weblink https://ranegroup.com/investors/rane-holdings-limited/.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/f2508eaf-efc9-4309-8c6d-36b6bc0652bb.pdf) |
| 16 Feb - Copies of extract of unaudited consolidated financial results of the Company for the quarter and nine months ended December 31, 2025 published on February 15, … | [Announcement under Regulation 30 (LODR)-Newspaper Publication 16 Feb - Copies of extract of unaudited consolidated financial results of the Company for the quarter and nine months ended December 31, 2025 published on February 15, …](https://www.bseindia.com/xml-data/corpfiling/AttachHis/f4c1a8ce-1915-4226-98c2-c4045078b4ef.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Oct 2022 | [Concall - Oct 2022](https://www.bseindia.com/xml-data/corpfiling/AttachHis/111da66d-d903-4e6a-850a-af05f00443a3.pdf) |
| Nov 2025 | [Concall - Nov 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/a2180914-f6b1-4c49-82c7-6fd632388219.pdf) |
| Nov 2024 | [Concall - Nov 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/a1dff7c4-dd44-403e-a057-5c8ff1d06d3d.pdf) |
| Nov 2021 | [Concall - Nov 2021](https://www.bseindia.com/xml-data/corpfiling/AttachHis/3b71d05f-4414-4d12-b4b4-7b4555dcd2c2.pdf) |
| Nov 2020 | [Concall - Nov 2020](https://www.bseindia.com/xml-data/corpfiling/AttachHis/258e5491-cbd4-401c-af16-0790bec900fd.pdf) |
| Nov 2019 | [Concall - Nov 2019](https://www.bseindia.com/xml-data/corpfiling/AttachHis/114ec15e-0840-4e17-b364-d2cdf8770477.pdf) |
| Nov 2018 | [Concall - Nov 2018](https://www.bseindia.com/xml-data/corpfiling/CorpAttachment/2018/11/ab74873b-4da1-4906-a04c-164d8c99b0d9.pdf) |
| May 2022 | [Concall - May 2022](https://www.bseindia.com/xml-data/corpfiling/AttachHis/b1fb35a6-b500-426d-bb55-3b4409990412.pdf) |
| May 2019 | [Concall - May 2019](https://www.bseindia.com/xml-data/corpfiling/AttachHis/0a5f3816-46e9-4e1e-a003-694c9c4a690b.pdf) |
| May 2018 | [Concall - May 2018](https://www.bseindia.com/xml-data/corpfiling/CorpAttachment/2018/5/3575887c-8636-42d5-b640-84f073cbcfe2.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/06804375-c2f2-48a6-acbb-3b8ffcfdd6e1.pdf) |
| from bse | [Financial Year 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/66c0a8ea-3720-4872-81a4-392d4081fa80.pdf) |
| from bse | [Annual Report 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/ec655021-f067-4cf5-99a1-af5a457b6b0e.pdf) |
| from bse | [Financial Year 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/1d248326-551d-440a-8359-f0aadd0e05f6.pdf) |
| from bse | [Annual Report 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/1acd4552-a38b-4925-b237-e4cab700f1b1.pdf) |
| from bse | [Financial Year 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/1c744c68-f7e0-405e-9cb1-a4119526bf5b.pdf) |
| from bse | [Financial Year 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/505800/73175505800.pdf) |
| from bse | [Financial Year 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/505800/68887505800.pdf) |
| from bse | [Financial Year 2020 from bse](https://www.bseindia.com/bseplus/AnnualReport/505800/5058000320.pdf) |
| from bse | [Financial Year 2019 from bse](https://www.bseindia.com/bseplus/AnnualReport/505800/5058000319.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T20:15:47.564Z.